Sens. Hassan, Cassidy Lead Push to Lower Prescription Drug Costs by Cracking Down on Lack of Patent Oversight
May 27, 2022
May 27, 2022
WASHINGTON, May 27 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
Senators Maggie Hassan (D-NH) and Bill Cassidy, MD (R-LA) are calling for federal agencies to close oversight gaps that delay generic drugs - and in turn keep drug prices high.
"The lack of coordination between the Patent and Trademark Office (PTO) and Food and Drug Administration (FDA) has allowed the pharmaceutical industry to obtain patents of questionable validity. Thr . . .
Senators Maggie Hassan (D-NH) and Bill Cassidy, MD (R-LA) are calling for federal agencies to close oversight gaps that delay generic drugs - and in turn keep drug prices high.
"The lack of coordination between the Patent and Trademark Office (PTO) and Food and Drug Administration (FDA) has allowed the pharmaceutical industry to obtain patents of questionable validity. Thr . . .